360 related articles for article (PubMed ID: 30282562)
1. Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.
Lim SY; Bae EH; Han KD; Jung JH; Choi HS; Kim HY; Kim CS; Ma SK; Kim SW
Lupus; 2018 Nov; 27(13):2050-2056. PubMed ID: 30282562
[TBL] [Abstract][Full Text] [Related]
2. Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.
Wu LS; Tang CH; Lin YS; Lin CP; Hung ST; Hwa HL; Luo SF; Chu PH
Am J Med Sci; 2014 Jan; 347(1):42-9. PubMed ID: 23255242
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.
Bae EH; Lim SY; Han KD; Jung JH; Choi HS; Kim CS; Ma SK; Kim SW
Lupus; 2019 Mar; 28(3):317-323. PubMed ID: 30712493
[TBL] [Abstract][Full Text] [Related]
4. Risk of infective endocarditis in patients with systemic lupus erythematosus in Taiwan: a nationwide population-based study.
Chang YS; Chang CC; Chen YH; Chen WS; Chen JH
Lupus; 2017 Oct; 26(11):1149-1156. PubMed ID: 28420053
[TBL] [Abstract][Full Text] [Related]
5. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.
Manzi S; Meilahn EN; Rairie JE; Conte CG; Medsger TA; Jansen-McWilliams L; D'Agostino RB; Kuller LH
Am J Epidemiol; 1997 Mar; 145(5):408-15. PubMed ID: 9048514
[TBL] [Abstract][Full Text] [Related]
6. Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.
Aviña-Zubieta JA; To F; Vostretsova K; De Vera M; Sayre EC; Esdaile JM
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):849-856. PubMed ID: 28129475
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events.
Smilowitz NR; Katz G; Buyon JP; Clancy RM; Berger JS
J Thromb Thrombolysis; 2018 Jan; 45(1):13-17. PubMed ID: 29230625
[TBL] [Abstract][Full Text] [Related]
9. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.
Hermansen ML; Lindhardsen J; Torp-Pedersen C; Faurschou M; Jacobsen S
Rheumatology (Oxford); 2017 May; 56(5):709-715. PubMed ID: 28053276
[TBL] [Abstract][Full Text] [Related]
10. Risks of interstitial cystitis among patients with systemic lupus erythematosus: A population-based cohort study.
Wen JY; Lo TS; Chuang YC; Ho CH; Long CY; Law KS; Tong YC; Wu MP
Int J Urol; 2019 Sep; 26(9):897-902. PubMed ID: 31311067
[TBL] [Abstract][Full Text] [Related]
11. Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study.
Han JY; Cho SK; Kim H; Jeon Y; Kang G; Jung SY; Jang EJ; Sung YK
Sci Rep; 2024 Jan; 14(1):1082. PubMed ID: 38212487
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.
Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH
Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102
[TBL] [Abstract][Full Text] [Related]
13. The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea.
Choi HS; Han KD; Jung JH; Kim CS; Bae EH; Ma SK; Kim SW
Medicine (Baltimore); 2019 Jul; 98(28):e16420. PubMed ID: 31305460
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
Ward MM
Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
[TBL] [Abstract][Full Text] [Related]
15. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythematosus: a nationwide, population-based cohort study.
Huang YF; Chang YS; Chen WS; Tsao YP; Wang WH; Liao HT; Tsai CY; Lai CC
Lupus; 2019 Jan; 28(1):19-26. PubMed ID: 30458691
[TBL] [Abstract][Full Text] [Related]
17. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
18. Tooth Loss Predicts Myocardial Infarction, Heart Failure, Stroke, and Death.
Lee HJ; Choi EK; Park JB; Han KD; Oh S
J Dent Res; 2019 Feb; 98(2):164-170. PubMed ID: 30782090
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus is a risk factor for atrial fibrillation: a nationwide, population-based study.
Lim SY; Bae EH; Han KD; Jung JH; Choi HS; Kim CS; Ma SK; Kim SW
Clin Exp Rheumatol; 2019; 37(6):1019-1025. PubMed ID: 30943134
[TBL] [Abstract][Full Text] [Related]
20. Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study.
Park CS; Choi EK; Han KD; Lee HJ; Rhee TM; Lee SR; Cha MJ; Lim WH; Kang SH; Oh S
Int J Epidemiol; 2018 Feb; 47(1):289-298. PubMed ID: 29025084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
